Mirum Pharmaceuticals Inc (MIRM)
SG&A Expense Growth
-15.43%
Quarterly · Period ending:
MIRM SG&A Expense Growth
Latest reported-15.43%period ending
Latest reported-15.43%period ending
MIRM Quarterly SG&A Growth (QoQ) (0.00% → -15.43%)
Latest values, visible window
High-resolution chart · PNG
MIRM sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -15.4272% | |
| 29.9509% | |
| 19.7351% | |
| -2.1743% | |
| 9.6697% | |
| 1.5414% | |
| 12.4345% | |
| 2.717% | |
| 7.8224% | |
| -1.1822% | |
| 26.4345% | |
| 10.8622% | |
| 9.0341% | |
| 14.1718% | |
| 17.5676% | |
| 7.3633% | |
| 9.6935% | |
| 0.4255% | |
| 9.6928% | |
| 29.9558% | |
| 40.8693% | |
| 31.1972% | |
| 26.0468% | |
| 13.685% | |
| 7.4595% | |
| 9.6774% | |
| 15.3722% | |
| 51.6564% | |
| 85.0871% | |
| 63.9975% | |
| 1,199.1935% | |
| 0% |